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Between 1986 and 1991 we implanted 331 consecutive Furlong hydroxyapatite-coated 
femoral components of a total hip replacement in 291 patients. A cemented acetabular 
prosthesis was used in 217 hips and a hydroxyapatite-coated component in 114. We 
describe the long-term clinical and radiological survival of the femoral component at a 
mean follow-up of 17.5 years (15 to 21). Only two patients (0.68%) were lost to follow-up. 
With revision of the femoral component for any reason as the endpoint, the survival at a 
mean of 17 years was 97.4% (95% confidence interval 94.1 to 99.5), and with revision for 
aseptic loosening as the endpoint it was 100%. The survival at a maximum of 21 years with 
revision of the femoral component for any reason as the endpoint was 97.4% (95% 
confidence interval 81.0 or 99.5). These results compare favourably with the best long-term 
results of cemented or uncemented femoral components used in total hip replacement.
 
The results of the titanium hydroxyapatite
(HA)-coated Furlong hip replacement (Joint
Replacement Instrumentation Ltd, London,
United Kingdom) have previously been
reported, showing survival of the femoral com-
ponent of 100% at ten years
 
1
 
 and of 99% at a
mean of 13 years.
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  We report the longest pro-
spective series to date of an HA-coated femoral
prosthesis.
 
Patients and Methods
 
Between 1986 and 1991, in Hastings, United
Kingdom, we performed 331 total hip
replacements (THRs) in 291 patients with a
mean age of 71.2 years (31.1 to 89.8). A total
of 40 patients had bilateral THRs, 30 under
one anaesthetic and ten in a staged procedure.
All the patients had a Furlong HA-coated
THR. The operation was performed via a
Watson-Jones approach by, or under the
supervision of a consultant orthopaedic sur-
geon (JANS).
A total of 217 THRs were undertaken using
a Furlong HA-coated femoral component and
a Furlong ultra-high-density-polyethylene
cemented acetabular component. The remain-
ing 114 THRs, operated on after 1 January
1990, had an HA-coated threaded acetabular
component (Joint Replacement Instrumenta-
tion Ltd) and a HA-coated Furlong femoral
component. A 32 mm modular ceramic head
was used in all patients. Each patient had three
doses of prophylactic antibiotics (cefuroxime)
and were allowed to bear weight fully immedi-
ately after surgery.
The patients were reviewed clinically and
radiologically at 6, 12, 26 and 52 weeks after
operation and annually thereafter. Antero-
posterior radiographs of the pelvis and lateral
radiographs of the hips were taken and the
Merle d’Aubigne and Postel hip score
 
3
 
 was used
for the assessment of pain, mobility and func-
tion.
The stability and fixation of the femoral
component was assessed by two independent
observers (SSR, CJ) by a consensus of opinion.
The appearance of radiolucencies around the
component according to Gruen, McNiece and
Amstutz
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was noted, as was subsidence on
serial radiographs, the presence of increased
bone density suggesting bony ingrowth, and
the appearance of radiolucent lines and pedes-
tal formation at the tip of the stem. An assess-
ment of the radiographs was also made for
evidence of stress shielding and of each Gruen
zone for osteopenia.
 
Results
 
The patients were followed up for a mean of
17.5 years (15 to 21). A total of 184 patients
(63.2%; 211 hips) had died by the final follow-
up. All had been reviewed within one year of
their death and were therefore included in the
survival analysis.
Of the remaining 107 patients with 120
THRs, 15 failed to attend the final review and
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were contacted via an extended telephone interview. Their
results are included in the study. Two hips in two patients
(0.68%) were lost to follow-up. One had moved abroad 2.5
years after THR and could not be contacted. The other had
a well functioning THR at six years post-operatively and
refused further review.
 
Clinical and radiological. 
 
The mean Merle D’Aubigne and
Postel
 
3
 
 score recorded for the 92 patients (105 hips) who
attended the latest follow-up was 5.63 (3 to 6) for pain,
5.42 (2 to 6) for mobility and 4.50 (0 to 6) for function.
No patient reported anterior thigh pain at any review.
Slight rounding of the femoral calcar under the collar
was seen in 43 of 105 hips (41%).
There were no cases of aseptic loosening of the femoral
component during the study period. In all cases, the fem-
oral component remained well-fixed with no measured
migration at the latest follow-up, with radiological evi-
dence of bonding in the form of spot-weld formation
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 into
the stem and a blastic reaction at its tip (Figs 1 and 2). Six
patients (1.8%) underwent revision of the femoral compo-
nent for trauma, sepsis or trunion fretting, at which stage
their well-fixed femoral component was removed (Table I).
Fig. 1
Anteroposterior pelvic radiograph showing well-fixed bilateral Furlong
hydroxyapatite-coated femoral components and threaded acetabular
components, 17 years after total hip replacement.
Table I. Details of the revisions of the femoral components
Case Time since THR* (yrs) Indication for revision Treatment
1 10 Traumatic loosening of both components following road 
traffic accident
One-stage revision of femoral component
2   7 Late infection following road traffic accident Two-stage revision of both components
3 13 Loosening of the acetabular component One-stage revision
Infection Two-stage revision of both components
4   1 Acetabular loosening leading to dissociation of ceramic head 
from trunnion
One-stage revision of femoral component 
and acetabulum
5   9 Sepsis Two-stage revision of femoral component
6   8 Peri-prosthetic fracture and loosening One-stage revision of femoral component
* THR, total hip replacement
Fig. 2
Lateral radiograph of the hip showing a well-fixed Furlong hydroxy-
apatite-coated total hip replacement 17 years after operation.
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There were 30 revisions (9.1%) of the acetabular
component for infection (3 hips), dislocation (4 hips),
aseptic loosening (18 hips) and polyethylene wear
(5 hips).
 
Per-operative fracture. 
 
There were 16 (4.8%) per-opera-
tive fractures, all of which were iatrogenic fractures of
the anterior femoral cortex. In 15 hips (15 patients) a
minor per-operative proximal fracture of the femur was
identified during implantation of the femoral compo-
nent, as previously described.
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 All patients with per-
operative fractures identified during surgery were mobi-
lised non-weight-bearing for six weeks. In one patient, a
cerclage wire was used to stabilise the fracture. All
patients with iatrogenic proximal fractures of the femur
sustained during insertion of the stem went on to unite
satisfactorily, and did not suffer any long-term conse-
quences.
 
Survival analysis. 
 
The life-table survival for the femoral
component (including the six revisions) at a mean of
17 years was 97.4% (95% confidence interval (CI) 94.1
to 99.5) and at a maximum of 21 years was 97.4% (95%
CI 81.0 to 99.5) (Table II, Fig. 3). Figure 4 shows the
worst case scenario, including the two patients lost to
follow-up.
 
Table II. 
 
Cumulative survival of the 331 hips (including the six revisions)
 
Years since operation Number of hips Failures Withdrawn Number at risk Cumulative survival (%) 95% CI
 
*
 
  1 331 1 14 324.0
 
99.7
 
99.1 to 100.0
  2 316 0   7 312.5
 
99.7
 
 99.1 to 100.0
  3 309 0 13 302.5
 
99.7
 
99.1 to 100.0
  4 296 0 22 285.0
 
99.7
 
99.1 to 100.0
  5 274 0 12 268.0
 
99.7
 
99.1 to 100.0
  6 262 0 15 254.5
 
99.7
 
99.0 to 100.0
  7 247 1   7 243.5
 
99.3
 
98.3 to 100.0
  8 239 1 18 230.0
 
98.9
 
97.6 to 100.0
  9 220 1   8 216.0
 
98.4
 
96.8 to 100.0
10 211 1 12 205.0
 
98.0
 
96.1 to 99.8
11 198 0 13 191.5
 
98.0
 
96.0 to 99.8
12 185 0 25 172.5
 
98.0
 
96.0 to 99.8
13 160 1 13 153.5
 
97.4
 
94.9 to 99.5
14 146 0   5 143.5
 
97.4
 
94.8 to 99.5
15 141 0 14 134.0
 
97.4 
 
94.8 to 99.5
16 127 0 36 109.0
 
97.4
 
94.6 to 99.5
17   91 0 36   73.0
 
97.4
 
94.1 to 99.5
18   55 0 20   45.0
 
97.4
 
93.3 to 99.5
19   35 0 21   24.5
 
97.4
 
92.2 to 99.5
20   14 0 11     8.5
 
97.4
 
89.4 to 99.5
21     3 0   3     1.5
 
97.4
 
81.0 to 99.5
* 95% CI, 95% confidence interval
C
u
m
u
la
ti
ve
 s
u
rv
iv
al
 (
%
)
60
40
20
0
80
100
Time since operation (yrs)
0 5 10 15 20 
Fig. 3
Kaplan Meier survival curve (with 95% confidence intervals) with
revision of the femoral component for any reason as the endpoint.
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Fig. 4
Kaplan Meier survival curve (with 95% confidence intervals) showing
the worst case scenario. The two cases lost to follow-up have been
included as stem failures.
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Discussion
 
Previous studies on the Furlong HA-coated femoral compo-
nent have shown excellent medium-term survival when
used as a primary
 
1,2,5,6
 
 or revision implant.
 
6,7
 
Our current series includes the first 100 Furlong HA-
coated THRs which were previously reported at a mean of
ten years (9 to 12), with a 100% follow-up and a survival of
98.95% at up to 12 years, with no cases of aseptic loosen-
ing of the femoral stem.
 
1
 
The Furlong HA-coated THR has also successfully been
used in younger patients.
 
5,6
 
 Singh et al
 
5
 
 reported the suc-
cessful use of this implant in patients below the age of 50
years with a 100% survival of the femoral component at a
mean of ten years (5.3 to 14.2). Robertson et al
 
6
 
 had a
95.3% survival of the femoral component at a mean of 8.8
years (5 to 13.8) in patients less than 55 years of age. They
did not identify any cases of aseptic loosening of the femo-
ral component.
The Furlong HA-coated THR has provided impressive
medium-term results as a revision implant.
 
7,8
 
 At a mean
follow-up of eight years (5 to 12.4) Trikha et al
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 reported
survival of the femoral component of 100% with aseptic
loosening as the endpoint, while Raman et al
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 found sim-
ilarly good results with survival of 95.6% at a mean
follow-up of 12 years when revising cemented THRs.
In our series of 331 consecutive THRs, survival of the fem-
oral component at a mean of 17 years was 97.4% (95% CI
94.1 to 99.5) and at a maximum of 21 years was 97.4% (95%
CI 81.0 to 99.5), with revision for any reason as the endpoint.
With aseptic loosening of the femoral component as the end-
point, the survival would be 100%. These figures are similar to
those in the literature for the same femoral component.
 
1,2,5-8
 
The length of follow-up achieved in this study is largely
attributable to the static elderly population of our region.
Only two of the 331 THRs were unaccounted for, thereby
reducing the errors in the survival analysis highlighted by
Murray, Britton and Bulstrode.
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The Merle D’Aubigne and Postel hip scoring system
 
3
 
 for the
assessment of pain, mobility and function has been used since
the commencement of this study. However, the mobility and
function scores achieved at the latest follow-up were influ-
enced by the advancing age of the patients as the follow-up
extended. This explains the good mean scores of 5.63 for pain
and 5.42 for mobility, but the relatively modest score of 4.50
for function.
The collar on the femoral component prevents early subsid-
ence of the prosthesis after implantation. Once bone has
bonded to the prosthesis, its function becomes redundant.
This may account for the rounding of the bone under the fem-
oral collar seen on the radiographs at the final follow-up.
Stress protection osteopenia occurs when a distally well-
fixed femoral component takes the load in preference to the
proximal femur. From the plain radiographs we were
unable to identify any consistent pattern of osteopenia in
our series and believe that the Furlong HA-coated femoral
component loads the entire femur surrounding it ade-
quately. However, we accept that we have not performed
bone densitometry of the proximal femur to accurately
quantify peri-prosthetic osteopenia.
A total of 16 peri-operative fractures occurred in our
series, 11 of which were seen in the first 100 THRs, as
reported previously,
 
1
 
 and comprised iatrogenic fractures of
the anterior femoral cortex. The prevalence of these frac-
tures in the early stages of the study most likely represents
the learning experience encountered with the use of any new
implant. Of the 16 fractures, 15 were proximal cracks of the
anterior femoral cortex and did not require supplementary
fixation. This type of fracture can be avoided by recognising
that adequate space needs to be cleared in the posterolateral
corner of the proximal femur to accommodate the relatively
bulky body of the implant. One fracture extended further
distally and required cerclage wire fixation to stabilise the
implant. Nevertheless, all fractures united satisfactorily and
there were no further complications.
Anterior thigh pain has been reported previously with
the use of uncemented hip prostheses.
 
10,11
 
 This was not the
case in our study. The absence of thigh pain in our study
may be related to the modulus of elasticity of the titanium
implant and to the bonding of bone throughout its length as
shown in a retrieval analysis.
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